Glucoglycinuria
WikiDoc Resources for Glucoglycinuria |
Articles |
---|
Most recent articles on Glucoglycinuria Most cited articles on Glucoglycinuria |
Media |
Powerpoint slides on Glucoglycinuria |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Glucoglycinuria at Clinical Trials.gov Trial results on Glucoglycinuria Clinical Trials on Glucoglycinuria at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Glucoglycinuria NICE Guidance on Glucoglycinuria
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Glucoglycinuria Discussion groups on Glucoglycinuria Patient Handouts on Glucoglycinuria Directions to Hospitals Treating Glucoglycinuria Risk calculators and risk factors for Glucoglycinuria
|
Healthcare Provider Resources |
Causes & Risk Factors for Glucoglycinuria |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Glucoglycinuria belongs to a group of inherited metabolic disorders which have in common elevations of serum Lysine levels. Enzyme deficiencies of alpha-aminoadipic semialdehyde dehydrogenase and the saccharopine dehydrogenases have been associated with hyperlysinemia.
Clinical manifestations include mental retardation, recurrent emesis, hypotonia, lethargy, diarrhea, and developmental delay. All disorders in this group are;
- Glucoglycinuria
- Glycinemia (with methylmalonic acidemia)
- Hyperglycinemia
- Hyperlysinemia
- Pipecolic acidemia
- Saccharopinuria
- Other disturbances of metabolism of glycine, threonine, serine, glutamine, and lysine [1]
References
- ↑ Menkes, Textbook of Child Neurology, 5th ed, p 56